Literature DB >> 9748176

Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism.

E Lundgren1, E Szabo, S Ljunghall, R Bergström, L Holmberg, J Rastad.   

Abstract

OBJECTIVE: To analyse sick leave in women at risk of primary hyperparathyroidism before its diagnosis.
DESIGN: Case-control study nested within a screened cohort of postmenopausal women. Cases were women with hyperparathyroidism without prior knowledge of their disease and no traditional symptoms or complications. Controls were women from the screened population without hyperparathyroidism.
SETTING: Population based screening within a Swedish community. SUBJECT: 48 case-control pairs of women aged 55-70 years. MAIN OUTCOME MEASURE: Sick leave during the 5 years before diagnosis.
RESULTS: Total duration of sickness benefits was longer in the cases than controls, and this discrepancy included sick leave on full time or half time and for periods of longer than a week. Cases had an increased risk of sick leave more than half of the investigated time compared with controls (odds ratio 12). Doctors' certificates showed that the overrepresented sick leave in the cases related mainly to cardiovascular diseases.
CONCLUSION: Asymptomatic mild primary hyperparathyroidism in postmenopausal women is accompanied by a previously unrecognised morbidity, which has consequences for clinical management of the disorder and its impact on the health economy.

Entities:  

Mesh:

Year:  1998        PMID: 9748176      PMCID: PMC31094          DOI: 10.1136/bmj.317.7162.848

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  15 in total

1.  Longitudinal studies of mild primary hyperparathyroidism.

Authors:  S Ljunghall; S Jakobsson; C Joborn; M Palmér; J Rastad; G Akerström
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

2.  Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention.

Authors:  A M Parfitt; D S Rao; M Kleerekoper
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

3.  The accordance of diagnoses in a computerized sick-leave register with doctor's certificates and medical records.

Authors:  L O Ljungdahl; P Bjurulf
Journal:  Scand J Soc Med       Date:  1991-09

4.  Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism.

Authors:  P Martin; P Bergmann; C Gillet; M Fuss; J Corvilain; J Van Geertruyden
Journal:  Arch Intern Med       Date:  1990-07

5.  Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course.

Authors:  D S Rao; R J Wilson; M Kleerekoper; A M Parfitt
Journal:  J Clin Endocrinol Metab       Date:  1988-12       Impact factor: 5.958

6.  Breast cancer screening with mammography: overview of Swedish randomised trials.

Authors:  L Nyström; L E Rutqvist; S Wall; A Lindgren; M Lindqvist; S Rydén; I Andersson; N Bjurstam; G Fagerberg; J Frisell
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

7.  Survival after the diagnosis of hyperparathyroidism: a population-based study.

Authors:  R A Wermers; S Khosla; E J Atkinson; C S Grant; S F Hodgson; W M O'Fallon; L J Melton
Journal:  Am J Med       Date:  1998-02       Impact factor: 4.965

8.  Repeated short-term sick-leave and quality of life. An evaluation of a clinical socio-medical intervention.

Authors:  J O Hörnquist; B Hansson; M Leijon; B Mikaelsson
Journal:  Scand J Soc Med       Date:  1990-06

9.  The influence of surgery on the risk of death in patients with primary hyperparathyroidism.

Authors:  G Hedbäck; A Odén; L E Tisell
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

10.  Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up.

Authors:  M Palmer; H O Adami; R Bergström; S Jakobsson; G Akerström; S Ljunghall
Journal:  Lancet       Date:  1987-01-10       Impact factor: 79.321

View more
  8 in total

Review 1.  Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk?

Authors:  J Rastad
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

Review 2.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

Review 3.  Primary hyperparathyroidism, cognition, and health-related quality of life.

Authors:  Laura H Coker; Kashemi Rorie; Larry Cantley; Kimberly Kirkland; David Stump; Nicole Burbank; Terry Tembreull; Jeff Williamson; Nancy Perrier
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

4.  Involvement of α-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism.

Authors:  Joerg Latus; Renate Lehmann; Meike Roesel; Peter Fritz; Niko Braun; Christoph Ulmer; Wolfgang Steurer; Dagmar Biegger; German Ott; Juergen Dippon; M Dominik Alscher; Martin Kimmel
Journal:  Endocrine       Date:  2013-01-20       Impact factor: 3.633

5.  Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.

Authors:  Lee F Starker; Annabelle L Fonseca; Annabelle Fonseca; Göran Akerström; Peyman Björklund; Gunnar Westin; Tobias Carling
Journal:  Endocrine       Date:  2012-05-11       Impact factor: 3.633

6.  Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism.

Authors:  Merih Baykan; Cihangir Erem; Turan Erdoğan; Arif Hacihasanoğlu; Omer Gedikli; Abdulkadir Kiriş; Mehmet Küçükosmanoğlu; Halil Onder Ersöz; Sükrü Celik
Journal:  Int J Cardiovasc Imaging       Date:  2006-10-12       Impact factor: 2.316

7.  Seventeen Cases of Primary Hyperparathyroidism in Pregnancy: A Call for Management Guidelines.

Authors:  Aimee Natasha DiMarco; Karim Meeran; Ioannis Christakis; Vinpreet Sodhi; Catherine Nelson-Piercy; Neil Samuel Tolley; Francesco Fausto Palazzo
Journal:  J Endocr Soc       Date:  2019-02-20

8.  Quality of life and health care consumption in primary care patients with elevated serum calcium concentrations in - a prospective, case control, study.

Authors:  Sofia Dalemo; Robert Eggertsen; Per Hjerpe; Svante Jansson; Kristina Bengtsson Boström
Journal:  BMC Fam Pract       Date:  2014-05-05       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.